U.S. sanctions kill Iranian cancer patients

The U.S. sanctions affects adversely Iranian patients, especially cancer patients, rising up import prices, blocking supply chains, and causing deadly drug shortages, Iranian officials say

While the new coronavirus causes deaths in Iran, many patients have struggled to find medicine due to the sanctions reinstated by the United States in 2018 after it withdrew from a nuclear deal on May 8, 2018.

Although humanitarian items are exempt from US sanctions on paper, banks declines transactions involving Iran to avoid being exposed to potential litigation.

There are the lack of equipment and spare parts in the pharmaceutical plantsAn Iranian pharmaceutical plant has been unable to produce a drug that is essential for treating leukemia for the past six months, according to the Iranian officials.

There are nearly 500,000 cancer patients in Iran, and it is the second biggest cause of death in the country, claiming 30,000 lives a year.

ILKHA

İlk yorum yazan siz olun
UYARI: Küfür, hakaret, rencide edici cümleler veya imalar, inançlara saldırı içeren, imla kuralları ile yazılmamış,
Türkçe karakter kullanılmayan ve büyük harflerle yazılmış yorumlar onaylanmamaktadır.

İngilizce Haberleri

Turkey, US hold high-level defense meeting in Washington
7 Azerbaijani soldiers killed in clashes with Armenian forces
Yapıcıoğlu: Turkey should make an intense effort to end Syrian conflict
Turkish Foreign Minister Çavuşoğlu to visit Moldova
A 5.0 magnitude earthquake hits northwestern Turkey